CPC A61F 2/18 (2013.01) [A61F 2/90 (2013.01); A61K 31/58 (2013.01); A61L 27/18 (2013.01); A61L 27/26 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); A61L 31/06 (2013.01); A61L 31/10 (2013.01); A61F 2/186 (2013.01); A61F 2210/0004 (2013.01); A61F 2250/0031 (2013.01); A61F 2250/0067 (2013.01); A61L 2300/222 (2013.01); A61L 2300/41 (2013.01); A61L 2300/604 (2013.01); A61L 2300/608 (2013.01)] | 9 Claims |
1. A method of treatment of a human patient, comprising:
a) providing a scaffold comprising
i) a first layer comprising mometasone furoate and a biodegradable polymer material and
ii) a therapeutic-agent-free polymer topcoat layer, said topcoat layer positioned on said first layer; and
b) delivering said scaffold to the middle meatus under conditions where the scaffold delivers said mometasone furoate from the middle meatus to the ethmoid sinuses of a human patient, wherein the scaffold is not placed in a sinus ostium.
|